TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

HEMERION

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

HEMERION

ST13

US500000090554690

Classe

5, 10, 42

Pedido

90554690

Registro

7697787

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

42

Atualização mais recente

18/02/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10, 42

Data de depósito

02/03/2021

Data de registro

18/02/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

18/02/2025

Última transação

18/02/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

01/10/2023

Primeiro uso no comércio

11/04/2024

Código do desenho

4

Tipo de titular

99

Localização do titular

Villeneuve-d'Ascq, FR

Examinador

PILARO, MARK F

Unidade examinadora

N90

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

H. T. (pessoa física)

Representantes

Pina Campagna CARTER, DELUCA AND FARRELL LLP

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical products for the prevention and treatment of cancer; pharmaceutical, medical and veterinary preparations for the prevention and treatment of cancer; Sanitary preparations for medical purposes; Pharmaceutical preparations for the diagnosis and treatment of oncological and inflammatory diseases and disorders; Medicinal preparations for the treatment of infectious diseases and for use in oncology

Classe 10

(Based on 44(e)) Surgical and medical apparatus and instruments, namely, surgical instruments and apparatus, medical devices for detecting and treating cancer, x-ray apparatus and surgical apparatus and instruments for medical use; Medical imaging apparatus; Medical instruments for diagnosis and treatment of cancer; Lasers for surgical and medical use; Medical apparatus for the treatment of cancerous tumors; Radiological apparatus for medical purposes; Medical imaging apparatus for use in the field of oncology for diagnostic purposes; Radiotherapy apparatus; Medical diagnostic apparatus for detecting or testing cancer; Implantable subcutaneous drug delivery apparatus, specifically, implantable drug delivery ports and implantable drug delivery pumps; fluid injectors for medical purposes; probes for medical purposes

Classe 42

(Based on 44(e)) Scientific research for medical and surgical purposes in the field of cancerous diseases; Pharmaceutical research and development; Scientific and medical research in the field of lasers; Scientific research for medical and surgical purposes in the field of oncology, specifically, cancerous diseases; Conducting clinical trials as pharmaceutical research for others in the pharmaceutical field; Conduction preclinical trials as pharmaceutical research for others in the pharmaceutical field; in-vitro testing services, specifically, in vitro pharmaceutical testing being pharmaceutical research in the pharmaceutical field; scientific studies and research for medical and surgical purposes in the field of oncology, specifically, cancerous diseases; medical, pharmacological, biological and chemical studies and research all being scientific research for surgical and medical purposes in the field of cancerous diseases; pharmaceutical research and development of new medical devices and pharmaceutical products; pharmaceutical research services, namely, performance of biological, chemical and pharmacological analyses of pharmaceutical products

Publicações

Histórico de despachos e eventos da marca no USPTO.

42 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

18/02/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

18/02/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

28/01/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

28/01/2025

DOCK

ASSIGNED TO EXAMINER

13/01/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/09/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/09/2024

IUAF

USE AMENDMENT FILED

10/07/2024

EISU

TEAS STATEMENT OF USE RECEIVED

10/07/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

23/01/2024

EX4G

SOU EXTENSION 4 GRANTED

19/01/2024

EXT4

SOU EXTENSION 4 FILED

19/01/2024

EEXT

SOU TEAS EXTENSION RECEIVED

19/01/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

22/07/2023

EX3G

SOU EXTENSION 3 GRANTED

20/07/2023

EXT3

SOU EXTENSION 3 FILED

20/07/2023

EEXT

SOU TEAS EXTENSION RECEIVED

20/07/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

13/01/2023

EX2G

SOU EXTENSION 2 GRANTED

11/01/2023

EXT2

SOU EXTENSION 2 FILED

11/01/2023

EEXT

SOU TEAS EXTENSION RECEIVED

11/01/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

29/06/2022

EX1G

SOU EXTENSION 1 GRANTED

27/06/2022

EXT1

SOU EXTENSION 1 FILED

27/06/2022

EEXT

SOU TEAS EXTENSION RECEIVED

27/06/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

25/01/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

30/11/2021

PUBO

PUBLISHED FOR OPPOSITION

30/11/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/11/2021

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

28/10/2021

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

22/10/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

21/10/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

21/10/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

21/10/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

21/10/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

21/10/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

28/09/2021

GNRT

NON-FINAL ACTION E-MAILED

28/09/2021

CNRT

NON-FINAL ACTION WRITTEN

28/09/2021

DOCK

ASSIGNED TO EXAMINER

22/09/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/06/2021

NWAP

NEW APPLICATION ENTERED

05/03/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace HEMERION ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.